Literature DB >> 12421992

Defective production of functional 98-kDa form of Elf-1 is responsible for the decreased expression of TCR zeta-chain in patients with systemic lupus erythematosus.

Yuang-Taung Juang1, Klaus Tenbrock, Madhusoodana P Nambiar, Mark F Gourley, G C Tsokos.   

Abstract

Systemic lupus erythematosus (SLE), the prototypic autoimmune disease, is characterized by defective expression of TCR zeta-chain. Elf-1 (E-74-like factor) is a member of the Ets (E-26-specific) family and is crucial for the basal transcription of TCR zeta-chain in Jurkat cells. We previously demonstrated that Elf-1 exists in the cytoplasm mainly as 80-kDa form and after phosphorylation and O-glycosylation it moves to the nucleus as a 98-kDa which binds DNA. We now demonstrate that Elf-1 is crucial for the transactivation of TCR zeta-chain promoter in normal and SLE T cells. Defective expression of TCR zeta-chain in SLE T cells is associated with two distinct molecular defects in the generation of the 98-kDa DNA binding Elf-1 form. In the first, the levels of the 98-kDa form were either decreased or absent. In the second, the apparent levels of the nuclear Elf-1 form were normal but included only two of the three bands into which the nuclear Elf-1 form separated in isoelectric focusing gels. Because both the transcription and the translation processes of Elf-1 gene are normal in SLE T cells, our data demonstrate that abnormal posttranslational mechanisms of the Elf-1 protein result in defective expression of functional Elf-1, and consequently, the transcriptional defect of TCR zeta-chain in patients of SLE.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12421992     DOI: 10.4049/jimmunol.169.10.6048

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

Review 1.  New insights into the pathogenesis of systemic lupus erythematosus.

Authors:  Vasileios C Kyttaris; Christina G Katsiari; Yuang-Taung Juang; George C Tsokos
Journal:  Curr Rheumatol Rep       Date:  2005-12       Impact factor: 4.592

2.  Altered regulation of IL-2 production in systemic lupus erythematosus: an evolving paradigm.

Authors:  Gary M Kammer
Journal:  J Clin Invest       Date:  2005-04       Impact factor: 14.808

Review 3.  T cell signaling abnormalities contribute to aberrant immune cell function and autoimmunity.

Authors:  Vaishali R Moulton; George C Tsokos
Journal:  J Clin Invest       Date:  2015-05-11       Impact factor: 14.808

4.  Systemic lupus erythematosus: from genes to organ damage.

Authors:  Vasileios C Kyttaris
Journal:  Methods Mol Biol       Date:  2010

5.  Transcriptional regulation of Elf-1: locus-wide analysis reveals four distinct promoters, a tissue-specific enhancer, control by PU.1 and the importance of Elf-1 downregulation for erythroid maturation.

Authors:  Fernando J Calero-Nieto; Andrew D Wood; Nicola K Wilson; Sarah Kinston; Josette-Renée Landry; Berthold Göttgens
Journal:  Nucleic Acids Res       Date:  2010-06-04       Impact factor: 16.971

6.  The RNA-stabilizing protein HuR regulates the expression of zeta chain of the human T cell receptor-associated CD3 complex.

Authors:  Vaishali R Moulton; Vasileios C Kyttaris; Yuang-Taung Juang; Bhabadeb Chowdhury; George C Tsokos
Journal:  J Biol Chem       Date:  2008-05-27       Impact factor: 5.157

7.  T cell receptor zeta reconstitution fails to restore responses of T cells rendered hyporesponsive by tumor necrosis factor alpha.

Authors:  Joanna M Clark; Alexander E Annenkov; Manvinder Panesar; Pia Isomäki; Yuti Chernajovsky; Andrew P Cope
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-26       Impact factor: 11.205

Review 8.  Novel molecular targets in the treatment of systemic lupus erythematosus.

Authors:  José C Crispín; George C Tsokos
Journal:  Autoimmun Rev       Date:  2007-12-04       Impact factor: 9.754

9.  PP2A dephosphorylates Elf-1 and determines the expression of CD3zeta and FcRgamma in human systemic lupus erythematosus T cells.

Authors:  Yuang-Taung Juang; Ying Wang; Guisen Jiang; Hai-Bin Peng; Sukran Ergin; Michelle Finnell; Abigail Magilavy; Vasileios C Kyttaris; George C Tsokos
Journal:  J Immunol       Date:  2008-09-01       Impact factor: 5.422

Review 10.  Systemic lupus erythematosus: new molecular targets.

Authors:  José C Crispín; Vasileios Kyttaris; Yuang-Taung Juang; George C Tsokos
Journal:  Ann Rheum Dis       Date:  2007-11       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.